Assenagon Asset Management S.A. Neuronetics, Inc. Transaction History

Assenagon Asset Management S.A.

$60.5 Billion
Q2 2025

A detailed history of Assenagon Asset Management S.A. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 13,761 shares of STIM stock, worth $53,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,761

Previous 97,656 85.91%

Holding current value

$53,667

Previous $359,000 86.63%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 11, 2025	SELL	$3.32 - $4.65 $278,531 - $390,111	-83,895 Reduced 85.91%	13,761 $48,000
Q1 2025 Apr 15, 2025	BUY	$1.49 - $5.54 $145,507 - $541,014	97,656 New	97,656 $359,000
Q3 2024 Oct 23, 2024	SELL	$0.73 - $2.0 $7,133 - $19,544	-9,772 Reduced 7.2%	125,974 $95,000
Q2 2024 Jul 18, 2024	BUY	$1.73 - $4.81 $90,738 - $252,284	52,450 Added 62.97%	135,746 $244,000
Q1 2024 Apr 24, 2024	SELL	$2.68 - $4.8 $7,680 - $13,756	-2,866 Reduced 3.33%	83,296 $396,000
Q4 2023 Jan 17, 2024	SELL	$1.05 - $2.9 $183,199 - $505,980	-174,476 Reduced 66.94%	86,162 $249,000
Q3 2023 Nov 06, 2023	SELL	$1.29 - $2.22 $1,548 - $2,664	-1,200 Reduced 0.46%	260,638 $351,000
Q3 2022 Oct 27, 2022	BUY	$2.35 - $4.66 $615,319 - $1.22 Million	261,838 New	261,838 $833,000
Q2 2022 Jul 27, 2022	SELL	$2.09 - $3.71 $39,292 - $69,748	-18,800 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$2.84 - $4.52 $53,392 - $84,975	18,800 New	18,800 $57,000
Q4 2021 Feb 01, 2022	SELL	$3.87 - $6.59 $338,257 - $575,998	-87,405 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$6.22 - $15.54 $1.23 Million - $3.08 Million	-198,459 Reduced 69.42%	87,405 $573,000
Q2 2021 Jul 15, 2021	BUY	$10.15 - $17.25 $2.9 Million - $4.93 Million	285,864 New	285,864 $4.58 Million

Others Institutions Holding STIM

# of Institutions

108

Shares Held

19.4M

Call Options Held

96.2K

Put Options Held

58.4K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $105M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Neuronetics, Inc. Transaction History